Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$94.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$62.4M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$29.7M |
| 4 |
Intercontinental Exchange
ICE
|
+$22.5M |
| 5 |
Boeing
BA
|
+$22.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$69.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$67.9M |
| 3 |
Wells Fargo
WFC
|
+$64.1M |
| 4 |
JPMorgan Chase
JPM
|
+$63.1M |
| 5 |
Pfizer
PFE
|
+$62.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.51% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 13.05% |
| 4 | Industrials | 11.46% |
| 5 | Energy | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$87.3B
| $326M | 0.62% |
12,530,446
-607,468
| -5% | -$14.6M |
|
27
Home Depot
HD
$337B
| $321M | 0.61% |
3,893,360
-64,816
| -2% | -$5.05M |
|
28
Amazon
AMZN
$2.44T
| $295M | 0.56% |
14,808,520
+518,920
| +4% | +$9.33M |
|
29
Philip Morris
PM
$309B
| $292M | 0.56% |
3,353,363
+87,922
| +3% | +$7.68M |
|
|
30
Boeing
BA
$169B
| $278M | 0.53% |
2,037,684
+171,518
| +9% | +$22.3M |
|
31
Amgen
AMGN
$209B
| $269M | 0.51% |
2,359,891
-231,665
| -9% | -$26.4M |
|
32
Walt Disney
DIS
$171B
| $263M | 0.5% |
3,445,150
+17,519
| +0.5% | +$1.21M |
|
33
Qualcomm
QCOM
$164B
| $254M | 0.48% |
3,423,749
+52,945
| +2% | +$3.73M |
|
34
3M
MMM
$91.8B
| $253M | 0.48% |
2,160,866
-18,761
| -0.9% | -$2M |
|
35
RTX Corp
RTX
$290B
| $251M | 0.48% |
3,508,137
-144,404
| -4% | -$9.84M |
|
36
Gilead Sciences
GILD
$165B
| $251M | 0.48% |
3,336,111
+93,306
| +3% | +$6.5M |
|
37
SLB Ltd
SLB
$72.7B
| $249M | 0.47% |
2,760,879
+75,014
| +3% | +$6.77M |
|
38
McDonald's
MCD
$193B
| $247M | 0.47% |
2,542,005
+112,289
| +5% | +$10.8M |
|
39
Medtronic
MDT
$112B
| $246M | 0.47% |
4,289,313
-90,154
| -2% | -$5.11M |
|
40
Bristol-Myers Squibb
BMY
$129B
| $246M | 0.47% |
4,624,777
+247,182
| +6% | +$12.6M |
|
41
Occidental Petroleum
OXY
$55.7B
| $239M | 0.46% |
2,627,819
-94,349
| -3% | -$8.61M |
|
42
AbbVie
ABBV
$465B
| $237M | 0.45% |
4,486,468
-1,072
| -0% | -$52.7K |
|
43
Visa
V
$701B
| $226M | 0.43% |
4,064,164
+72,384
| +2% | +$3.65M |
|
|
CELG
44
DELISTED
Celgene Corp
CELG
| $226M | 0.43% |
2,676,626
-439,462
| -14% | -$34.8M |
|
45
Altria Group
MO
$125B
| $219M | 0.42% |
5,693,575
+312,629
| +6% | +$11.5M |
|
46
HP
HPQ
$26B
| $205M | 0.39% |
16,128,254
+591,805
| +4% | +$6.8M |
|
47
CVS Health
CVS
$135B
| $196M | 0.37% |
2,742,961
+6,861
| +0.3% | +$441K |
|
|
WBA
48
DELISTED
Walgreens Boots Alliance
WBA
| $188M | 0.36% |
3,265,320
+511,134
| +19% | +$29.7M |
|
49
Honeywell
HON
$76.4B
| $186M | 0.35% |
2,269,686
-148,076
| -6% | -$11.6M |
|
50
DuPont de Nemours
DD
$18.6B
| $186M | 0.35% |
1,656,559
-225,194
| -12% | -$23.1M |
|
Similar funds
Charles Schwab's Q4 2013 Portfolio in Review
As of Q4 2013, Charles Schwab held 3,132 positions worth $52.5B, up 7% from $49.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q4 2013: portfolio turnover was 4.1%. Charles Schwab opened 75 new positions and exited 54, leaving the 3,132-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- Charles Schwab's largest Q4 2013 buy was Allergan plc: 398,955 shares worth $67M.
- Charles Schwab added most to Meta Platforms (Facebook) in Q4 2013, an estimated $94.5M increase.
- Charles Schwab's biggest Q4 2013 reduction was Apple, cutting an estimated $69.9M.
- Charles Schwab fully exited DELL INC in Q4 2013, selling an estimated $45.2M.
- Charles Schwab's ten largest holdings make up 14% of its $52.5B portfolio in Q4 2013.
- Charles Schwab opened 75 new positions and closed 54 in Q4 2013.
- Charles Schwab's portfolio value rose 7% quarter-over-quarter to $52.5B.
Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.